Press "Enter" to skip to content

Ulcerative Colitis Market 2019 | Rising Status of Key Players, Industry Size & Share, Growth Factors, New Technologies Revenue Forecast by 2024

Ulcerative

The “Ulcerative Colitis Market” report 2019 provides information for market players, stakeholders, investors, and business strategists to achieve a leading position the market. It maintains the record of Unusual growth strategies adopted by various companies are creating new standards for competition in the global Ulcerative Colitis market. Businesses around the world are aiming at increasing their profit margin and establishing a stronghold in the global market. The impact of prevailing regulatory scenario on both regional and worldwide Ulcerative Colitis market is provided in detail in the report.

Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14098962  

Ulcerative Colitis Market Covers Key Players:

  • AbbVie Inc.
  • Bausch Health Companies Inc. (Salix Pharmaceutical)
  • Boehringer Ingelheim GmbH
  • Johnson and Johnson
  • Merck & Co.
  • Novartis AG
  • Shire
  • Takeda Pharmaceuticals
  • Teva Pharmaceuticals Ltd
  • Pfizer Inc.

    Market Overview:

  • The ulcerative colitis market was valued at USD 6,854.47 million in 2018, and is also expected to register a CAGR of 4.86% during the forecast period (2019-2024). Ulcerative colitis (UC) is the most common form of inflammatory bowel disease which affects several people. From a global perspective, several research studies in 2018 have reported annual incidence rates of UC ranging from 0.5 to 24.5 cases per 100,000 people. On the other hand, incidences have been increasing in Asian and South European countries. In the United States, UC affects an estimated 500,000 people and is the cause of 250,000 doctor visits and 30,000 hospitalizations, each year. UC has an uneven presence in major geographical regions across the world. It is common in most of Europe and North America and uncommon in most of the developing Asian countries. UC is more prevalent among males and has a regional north-to-south variation. One potential explanation is the differences in exposure to ultraviolet light, resulting in relative vitamin D deficiency in countries close to the Arctic. People who live in lower latitudes are more likely to develop UC than those in higher latitudes.
  • According to the Centers for Disease Control and Prevention (CDC), in 2015, 1.3% of US adults (3 million) reported that they were diagnosed with IBD (either Crohn’s disease or UC). This was a large increase in number from 1999 (0.9% or 2 million adults). According to an article published in PubMed, the highest reported prevalence values were in Europe (UC – 505 per 100,000 people in Norway, Crohn’s disease – 322 per 100,000 people in Germany) and North America (UC – 286 per 100,000 people in the United States, Crohn’s disease – 319 per 100,000 people in Canada). The high prevalence of the disease is driving the market.

    Report Highlights:

    • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
    • Market forecasts till 2024, using estimated market values as the base numbers
    • Key market trends across the business segments, Regions and Countries
    • Key developments and strategies observed in the market
    • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
    • In-depth company profiles of key players and upcoming prominent players
    • Growth prospects among the emerging nations through 2024
    • Ulcerative Colitis Market opportunities and recommendations for new investments

    For More Information or Query or Customization Before Buying, Visit athttps://www.industryresearch.co/enquiry/pre-order-enquiry/14098962

    Scope of the Report:

  • As per the , ulcerative colitis is a chronic, inflammatory bowel disease that causes inflammation in the digestive tract. Treatment for ulcerative colitis includes medication and surgery. However, the scope of this report includes only medications for the ulcerative colitis disease.

    Key Market Trends:

    Ulcerative Proctitis Segment is Expected to Experience the Fastest Growth during the Forecast Period

    Ulcerative proctitis is one of the types of ulcerative colitis. It is considered as the initial manifestation of ulcerative colitis, in which fine ulcerations in the inner linings of mucosa of the large intestine are seen. A survey was conducted by NIH in 2016, to understand the prevalence of disease, which gave results, such as 25% of the pediatric patients surveyed had the disease, and 17 to 21% of the adult patients had ulcerative proctitis. As per this data obtained by the survey, NIH stated that there was a rise in the number of patients suffering from ulcerative proctitis, compared to the previous years. Hence, this segment, by disease type, is believed to experience growth in the future.

    North America Region Holds the Largest Market Share of the Ulcerative Colitis Market Currently and is Believed to Follow the Same Trend over the Forecast Period

    North America is expected to lead the ulcerative colitis market, owing to the presence of key players and increasing prevalence of the disease in the region, along with the continuing funding for the development of new therapeutics for the treatment of the condition.

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14098962

    Detailed TOC of Ulcerative Colitis Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 High Global Incidence and Prevalence of Ulcerative Colitis
    4.2.2 New Product Launches in the Market
    4.2.3 Increase in Patient Assistance Programs
    4.3 Market Restraints
    4.3.1 High Levels of Unmet Clinical Need in Ulcerative Colitis (UC)
    4.3.2 Side-effects of Medications
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Drug Type
    5.1.1 Anti-Inflammatory Drugs
    5.1.1.1 Aminosalicylates
    5.1.1.2 Corticosteroids
    5.1.2 Anti-TNF biologics
    5.1.3 Immunosuppressant
    5.1.4 Calcineurin Inhibitors
    5.1.5 Other Drug Types
    5.2 By Disease Type
    5.2.1 Ulcerative Proctitis
    5.2.2 Proctosigmoiditis
    5.2.3 Left-sided Colitis
    5.2.4 Pancolitis or Universal Colitis
    5.2.5 Fulminant Colitis
    5.3 Geography
    5.3.1 North America
    5.3.1.1 US
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 Germany
    5.3.2.2 UK
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Middle East & Africa
    5.3.4.1 GCC
    5.3.4.2 South Africa
    5.3.4.3 Rest of Middle East & Africa
    5.3.5 South America
    5.3.5.1 Brazil
    5.3.5.2 Argentina
    5.3.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 AbbVie Inc.
    6.1.2 Bausch Health Companies Inc. (Salix Pharmaceutical)
    6.1.3 Boehringer Ingelheim GmbH
    6.1.4 Johnson and Johnson
    6.1.5 Merck & Co.
    6.1.6 Novartis AG
    6.1.7 Shire
    6.1.8 Takeda Pharmaceuticals
    6.1.9 Teva Pharmaceuticals Ltd
    6.1.10 Pfizer Inc.

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Global Arc Welding Machinery Market Share, Size 2019 Movements by Trend Analysis, Progression Status, Revenue Expectation to 2024 | Research Report by Industry Research Biz

    Soya Sauce Market 2019 – Business Size, Share, Opportunities, Future Trends, Top Key Players, Market Share and Global Analysis by Forecast to 2024

    Dinnerware Market 2019-2023 | Report includes Industrial potential Growth with Market share analysis and also include Key Players, Industry Challenges, Key Vendors, Drivers, Trends

    Clear Brine Fluids Market: Global Enhancement Study by Market Overview, Summary Methodology, Size and Growth Over the Forecast 2025